|
In this section details of:
Research Information
- New DNA Test -
Genetic Inheritance
of PRA
|
|
|
- · Dr Gary Johnson (UMC) and Dr Cathryn
Mellersh (AHT) have identified a DNA mutation that is a major
risk factor for development of Progressive Retinal Atrophy (PRA)
in English Springer Spaniels
- · A DNA test is available for breeders,
along with information about what the test can and cannot tell
them.
- · The percentage of English Springer
Spaniels testing as affected or carrier for this mutation is
very high. (80% of the dogs tested in the USA during the research
tested as affected or carrier for this mutation)
- · It is likely to take several generations
to reduce the frequency of this mutation in the ESS population.
- · Additional research in the USA,
funded by the ESSFTA Foundation and the AKC Canine Health Foundation,
has been initiated to help answer the questions that remain
unexplained by the discovery of this mutation.
- · More additional important information
about this discovery can be found at www.englishspringer.org
and www.sesss.co.uk .
|
| Dr Mellersh recently published information on
a mutation found to cause a recessive cone-rod form of PRA in Miniature
Longhaired Dachshunds. In a limited survey, Dr. Mellersh also found
the mutation to be present in ESS. Because of this, Masters student
Xuhua Chen from Dr Johnson's USA laboratory tested over 1100 ESS
DNA samples and found that dogs that inherited the mutation from
both their sire and dam were approximately 20 times more likely
to develop PRA compared to other ESS. Preliminary ERG clinical studies
by Dr Kristina Narfstrom, Laboratory for Comparative Ophthalmology,
University of Missouri-Columbia, suggest that ESS have a cone-rod
form of PRA similar to that found in the Dachshunds. |
| It is important to note that there are a large
number of dogs that have tested as genetically affected, but are
reported as clinically normal by their owners. This is also similar
to the situation in Miniature Longhaired Dachshunds. With the wide
range of age of onset observed for PRA in ESS, it may be that many
of these dogs will develop symptoms eventually. It is also possible
that that these dogs have some loss of visual function that has
not yet been detected by the owner. |
The good news - a DNA test is now available that
clearly identifies dogs that are clear (have 2 normal copies of
the gene), those who are carriers (have one normal copy of the gene
and one mutated copy of the gene), and those who are at much higher
risk for developing PRA (have 2 mutated copies of the gene). Wise
use of this test can reduce the incidence of dogs at risk for PRA
in future generations.
The bad news - In the USA only 20% of the 1100-plus ESS's genotyped
during the research tested as clear or normal. 38% tested as carriers,
and 42% tested as genetically affected. Should the same statistics
follow in the UK/Europe, eliminating all dogs testing as affected
from breeding programmes would have a major impact on the Breed,
and would have the potential to devastate successful breeding programmes.
Reducing the incidence of dogs at risk for PRA, while maintaining
genetic diversity and positive qualities present in the Breed, is
likely to be a slow process and will take several generations.
The DNA test is accurate and valid in being able to determine the
genetic status of each dog. However, it is not able to predict at
what age a genetically affected dog may become clinically affected.
We are aware that the age at which dogs develop PRA can vary dramatically.
Additional research is being carried out to help us understand why
some genetically affected dogs develop PRA early and others later.
This research is likely to take some time, and in the meantime,
therefore, the AHT feels it is in the Breed's best interests to
make the DNA test available now rather than wait 2 or 3 years until
we understand the story completely. From experience with the Miniature
Longhaired Dachshunds PRA, there is a wide range of variation, both
in terms of clinical presentation and the degree of visual impairment
that is associated with this mutation. Dogs that are DNA tested
as being affected may themselves not develop the disease until relatively
late in life, but it may well be possible for offspring of those
dogs to display an earlier, more progressive form of PRA, depending
on other genetic variants that they do or do not inherit.
|
| For a detailed explanation of how this form of
genetic inheritance is passed down, please refer to our document
"Genetic
Inheritance" at this Website. |
| All the UK ESS Breed Clubs will be consulted
to agree a Code of Ethics and Guidance in order to help ESS breeders
understand, assess and minimize the risks to their future breeding
programmes. |
|
Dr Gary Johnson
|
|
Dr Cathryn Mellersh
|
|
|
|
|
|